Pages that link to "Q43665637"

The following pages link to Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration (Q43665637):

Displaying 49 items.

• Case studies for practical food effect assessments across BCS/BDDCS class compounds using in silico, in vitro, and preclinical in vivo data (Q30576914) (← links)
• In vitro simulation of food effect on dissolution of deramciclane film-coated tablets and correlation with in vivo data in healthy volunteers (Q30674700) (← links)
• Comparison of simulated cumulative drug versus time data sets with indices (Q30883620) (← links)
• Multivariate data analysis of factors affecting the in vitro dissolution rate and the apparent solubility for a model basic drug substance in aqueous media (Q33548379) (← links)
• Analytical methods for dissolution testing of nanosized drugs (Q34299947) (← links)
• On the assessment of effects of food on the pharmacokinetics of drugs in early development (Q34642102) (← links)
• Nanosuspensions in drug delivery (Q35876031) (← links)
• Predictive models for oral drug absorption: from in silico methods to integrated dynamical models (Q36909311) (← links)
• Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation (Q37008900) (← links)
• Predicting pharmacokinetics of drugs using physiologically based modeling--application to food effects (Q37149095) (← links)
• Current methods for predicting human food effect (Q37171894) (← links)
• Dissolution of pentoxifylline from extended release formulations. Researches concerning development of a biorelevant test (Q37622445) (← links)
• An update on computational oral absorption simulation (Q37937047) (← links)
• Biorelevant in-vitro performance testing of orally administered dosage forms (Q38017705) (← links)
• Coupling biorelevant dissolution methods with physiologically based pharmacokinetic modelling to forecast in-vivo performance of solid oral dosage forms (Q38112181) (← links)
• Pros and cons of methods used for the prediction of oral drug absorption. (Q38177366) (← links)
• Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead (Q38199539) (← links)
• In vitro-in vivo correlations: general concepts, methodologies and regulatory applications (Q38541574) (← links)
• Approaches for Establishing Clinically Relevant Dissolution Specifications for Immediate Release Solid Oral Dosage Forms (Q38612998) (← links)
• Comparison of dissolution profiles for sustained release resinates of BCS class I drugs using USP apparatus 2 and 4: a technical note. (Q42204577) (← links)
• The application of modified flow-through cell apparatus for the assessment of chlorhexidine dihydrochloride release from lozenges containing sorbitol (Q42942873) (← links)
• Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine (Q44773921) (← links)
• Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects. (Q44852635) (← links)
• Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: Case example nelfinavir (Q45397786) (← links)
• Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation. (Q46534443) (← links)
• Identification of key factors affecting the oral absorption of salts of lipophilic weak acids: a case example (Q46573336) (← links)
• Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update (Q47779125) (← links)
• Predictive Performance of Physiologically Based Pharmacokinetic Models for the Effect of Food on Oral Drug Absorption: Current Status (Q49716638) (← links)
• Innovative therapeutics: from molecules to medicines. 27 June-7 July 2004, Parma, Italy (Q50772852) (← links)
• In Vitro Dissolution/Permeation System to Predict the Oral Absorption of Poorly Water-Soluble Drugs: Effect of Food and Dose Strength on It (Q51377835) (← links)
• Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs (Q51379052) (← links)
• Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles (Q51386964) (← links)
• The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs (Q51405119) (← links)
• Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling (Q51485283) (← links)
• Intestinal permeability and excretion into bile control the arrival of amlodipine into the systemic circulation after oral administration. (Q51497299) (← links)
• Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents (Q51497759) (← links)
• Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies (Q51507068) (← links)
• Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test. (Q52668360) (← links)
• Prediction of in-vivo pharmacokinetic profile for immediate and modified release oral dosage forms of furosemide using an in-vitro-in-silico-in-vivo approach. (Q53621585) (← links)
• Crystallization from Supersaturated Solutions: Role of Lecithin and Composite Simulated Intestinal Fluid (Q57117147) (← links)
• First-Principles and Empirical Approaches to Predicting In Vitro Dissolution for Pharmaceutical Formulation and Process Development and for Product Release Testing (Q64116995) (← links)
• Low dose lipid formulations: effects on gastric emptying and biliary secretion (Q80686294) (← links)
• A novel strategy for physiologically based predictions of human pharmacokinetics (Q83204523) (← links)
• In Vivo Bioequivalence and In Vitro Similarity Factor (f2) for Dissolution Profile Comparisons of Extended Release Formulations: How and When Do They Match? (Q83348285) (← links)
• Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu (Q83461108) (← links)
• Supersaturation–Nucleation Behavior of Poorly Soluble Drugs and its Impact on the Oral Absorption of Drugs in Thermodynamically High-Energy Forms (Q84945889) (← links)
• In Vivo Fluid Volume in Rat Gastrointestinal Tract: Kinetic Analysis on the Luminal Concentration of Nonabsorbable FITC-Dextran After Oral Administration (Q90336650) (← links)
• Integration of In Silico Pharmacokinetic Modeling Approaches Into In Vitro Dissolution Profiles to Predict Bioavailability of a Poorly Soluble Compound (Q91670916) (← links)
• Suitability of the z-Factor for Dissolution Simulation of Solid Oral Dosage Forms: Potential Pitfalls and Refinements (Q96124374) (← links)